Intramuscular Antibiotic for Kidney Infection (Pyelonephritis)
For acute pyelonephritis requiring parenteral therapy, give ceftriaxone 1 gram IM as a single dose, followed by oral antibiotics based on local resistance patterns. 1
Primary Recommendation
The IDSA/ESMID guidelines explicitly recommend ceftriaxone 1 g as a one-time long-acting parenteral antimicrobial for outpatient management of acute pyelonephritis 1. The guidelines specifically note that "the parenteral agent may be administered via the intramuscular route if the intravenous route is not available" 1.
When to Use IM Antibiotics
Use a single IM dose of ceftriaxone in these scenarios:
- Fluoroquinolone resistance >10% in your community - an initial IM dose is recommended before starting oral therapy 1
- Using oral beta-lactams - these are less effective for pyelonephritis, so an initial IM dose improves outcomes 1
- Using trimethoprim-sulfamethoxazole empirically when susceptibility is unknown 1
- Patient unable to tolerate oral medications initially but doesn't require hospitalization
Alternative IM Option
A consolidated 24-hour dose of an aminoglycoside (e.g., gentamicin 5-7 mg/kg as a single dose) is an acceptable alternative to ceftriaxone 1. However, ceftriaxone is generally preferred due to:
- Better safety profile (no nephrotoxicity or ototoxicity risk)
- No need for therapeutic drug monitoring
- More clinical experience in outpatient settings
Follow-Up Oral Therapy
After the IM dose, continue with oral antibiotics for 5-14 days depending on the agent chosen 1:
- Fluoroquinolones (if local resistance <10%): Ciprofloxacin 500 mg twice daily for 7 days OR levofloxacin 750 mg daily for 5 days 1
- Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 14 days (if susceptible) 1
- Oral cephalosporins: 10-14 days (less preferred due to inferior efficacy) 1
Critical Caveats
- Always obtain urine culture before starting antibiotics and adjust therapy based on susceptibility results 1
- Hospitalize if: severe illness, inability to maintain oral hydration, pregnancy, suspected obstruction, or immunocompromised state 1
- Avoid nitrofurantoin and fosfomycin for pyelonephritis - insufficient tissue penetration despite adequate urinary concentrations 2
- The newer 2024 EAU guidelines confirm ceftriaxone 1-2 g daily as appropriate parenteral therapy, though they focus primarily on IV administration 2
Practical Algorithm
- Confirm clinical diagnosis of pyelonephritis (fever, flank pain, CVA tenderness)
- Obtain urine culture and blood cultures if severely ill
- Assess local fluoroquinolone resistance rates
- If resistance >10% OR using non-fluoroquinolone oral therapy: Give ceftriaxone 1 g IM once
- Start appropriate oral antibiotic immediately after IM dose
- Reassess at 48-72 hours - if not improving, obtain imaging and consider hospitalization
- Adjust antibiotics once culture results available